Archives

by in
Entry Author Date Location
Bio Venture Specialists Advent Raise $235M For European, U.S. Deals 10/28/14 National
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
Atara Bio Pays the Price for Delayed IPO, Sinks in Debut 10/16/14 San Francisco
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Raleigh-Durham Roundup: Tengion, IBM, Velocity, & More 09/29/14 Raleigh Durham
Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program 09/29/14 San Francisco
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Merrimack, Baxter Ink $970M+ Deal for Pancreatic Cancer Drug 09/24/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Seattle Jobs? Big Biotech Gives And Takes Away (Mostly The Latter) 07/29/14 Seattle
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
NYCEDC Eyes VC Partners to Back Medtech, Diagnostics Startups 07/16/14 New York
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
Celgene Drug Misses Mark in Spinal Arthritis Study 07/09/14 New York
Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund 07/08/14 San Francisco
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
GlobeImmune Cuts Size of Pending IPO by 29 Percent 05/22/14 Boulder/Denver
Page 2 of 9 « previous page · next page »